Posterior capsular opacification: a problem reduced but not yet eradicated
- PMID: 19365040
- DOI: 10.1001/archophthalmol.2009.3
Posterior capsular opacification: a problem reduced but not yet eradicated
Abstract
Posterior capsular opacification (PCO) is the most frequent complication of cataract surgery. Advances in surgical techniques, intraocular lens materials, and designs have reduced the PCO rate, but it is still a significant problem. The only effective treatment for PCO, Nd:YAG laser capsulotomy carries vision-related complications and risks and puts a significant financial burden on the health care system. This review contains current knowledge about the mechanisms of PCO development. Posterior capsular opacification is caused mainly by remnant lens epithelial cell proliferation and migration, epithelial-mesenchymal transition, collagen deposition, and lens fiber generation. All of these processes are influenced by cytokines, growth factors, and extracellular matrix proteins. We also describe advances and improvements in surgical techniques, intraocular lens materials, and the designs and use of therapeutic agents leading to safe, effective, and less expensive strategies to eradicate PCO.
Similar articles
-
Posterior capsule opacification: a review of the aetiopathogenesis, experimental and clinical studies and factors for prevention.Indian J Ophthalmol. 2004 Jun;52(2):99-112. Indian J Ophthalmol. 2004. PMID: 15283214 Review.
-
Update on fixation of rigid and foldable posterior chamber intraocular lenses. Part II: Choosing the correct haptic fixation and intraocular lens design to help eradicate posterior capsule opacification.Ophthalmology. 1999 May;106(5):891-900. doi: 10.1016/S0161-6420(99)00506-0. Ophthalmology. 1999. PMID: 10328386
-
[Posterior capsule opacification: incidence and pathogenesis].Medicina (Kaunas). 2003;39(9):830-7. Medicina (Kaunas). 2003. PMID: 14515044 Review. Lithuanian.
-
Optic edge design as long-term factor for posterior capsular opacification rates.Ophthalmology. 2008 Aug;115(8):1308-14, 1314.e1-3. doi: 10.1016/j.ophtha.2008.01.002. Epub 2008 Mar 5. Ophthalmology. 2008. PMID: 18321585 Clinical Trial.
-
Posterior capsule opacification.Curr Opin Ophthalmol. 2006 Feb;17(1):45-53. doi: 10.1097/01.icu.0000193074.24746.e6. Curr Opin Ophthalmol. 2006. PMID: 16436924 Review.
Cited by
-
Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells.Mol Vis. 2012;18:22-8. Epub 2012 Jan 10. Mol Vis. 2012. PMID: 22259221 Free PMC article.
-
AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells.Glycoconj J. 2016 Aug;33(4):631-43. doi: 10.1007/s10719-016-9686-y. Epub 2016 Jun 4. Glycoconj J. 2016. PMID: 27263094 Free PMC article.
-
Effect of Nd:YAG Laser Capsulotomy on Anterior Segment Parameters in Patients with Posterior Capsular Opacification after Phacovitrectomy.Korean J Ophthalmol. 2018 Oct;32(5):369-375. doi: 10.3341/kjo.2018.0020. Korean J Ophthalmol. 2018. PMID: 30311459 Free PMC article.
-
Epithelial-Mesenchymal Transition (EMT).Int J Mol Sci. 2023 Jul 13;24(14):11386. doi: 10.3390/ijms241411386. Int J Mol Sci. 2023. PMID: 37511145 Free PMC article.
-
Improvement of visual acuity in diabetic and nondiabetic patients after Nd:YAG laser capsulotomy.Clin Ophthalmol. 2013;7:2011-7. doi: 10.2147/OPTH.S50898. Epub 2013 Oct 11. Clin Ophthalmol. 2013. PMID: 24143068 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical